Avenue Therapeutics ATXI

$ 1.8 0.0%

Quarterly report 2024-Q3
added 11-14-2024

Avenue Therapeutics Balance Sheet 2011-2024 | ATXI

Annual Balance Sheet Avenue Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-	-	-3.13 K	-8.74 M	-2.67 M	-11.8 M	5.68 M	3.85 M	-	-	-	-
Long Term Debt	-	-	-	-	-	-	-	2.03 M	2.7 M	-	-	-	-
Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	2.03 M	2.7 M	-	-	-	-
Total Current Liabilities	1.2 M	3.58 M	509 K	886 K	2.12 M	5.16 M	2.79 M	-	-	-	-	-	-
Total Liabilities	1.2 M	3.58 M	509 K	886	2.12 M	5.16 M	2.79 M	8.44 M	5.15 M	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-90.9 M	-80.6 M	-77 M	-	-68.1 M	-42.2 M	-20.7 M	-8.4 M	-5.23 M	-	-	-	-
Total Assets	1.85 M	6.84 M	3.96 M	3.24 K	8.92 M	4.52 M	22.2 M	197 K	14 K	-	-	-	-
Cash and Cash Equivalents	1.78 M	6.71 M	3.76 M	3.13 M	8.74 M	2.67 M	11.8 M	197 K	-	-	-	-	-
Book Value	654 K	3.27 M	3.45 M	2.36 K	6.8 M	-631 K	19.4 M	-8.25 M	-5.14 M	-	-	-	-
Total Shareholders Equity	1.58 M	3.9 M	3.45 M	2.36 M	6.8 M	-631 K	19.4 M	-8.25 M	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Avenue Therapeutics

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	973 K	1.16 M	1.41 M	1.2 M	5.02 M	7.81 M	10.6 M	3.58 M	614 K	407 K	797 K	509 K	848 K	549 K	469 K	886 K	886 K	886 K	886 K	2.12 M	2.12 M	2.12 M	2.12 M	5.16 M	5.16 M	5.16 M	5.16 M	2.79 M	2.79 M	2.79 M	2.79 M	8.44 M	8.44 M	8.44 M	8.44 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-101 M	-98 M	-95.3 M	-90.9 M	-91.6 M	-92.1 M	-88.1 M	-80.6 M	-81.1 M	-80.5 M	-79.9 M	-77 M	-76.1 M	-75.2 M	-74.3 M	-73.3 M	-73.3 M	-73.3 M	-73.3 M	-68.1 M	-68.1 M	-68.1 M	-68.1 M	-42.2 M	-42.2 M	-42.2 M	-42.2 M	-20.7 M	-20.7 M	-20.7 M	-20.7 M	-8.4 M	-8.4 M	-8.4 M	-8.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	2.62 M	4.99 M	3.31 M	1.85 M	502 K	1.67 M	8.45 M	6.84 M	575 K	1 M	1.96 M	3.96 M	688 K	1.19 M	1.94 M	3.24 M	3.24 M	3.24 M	3.24 M	8.92 M	8.92 M	8.92 M	8.92 M	4.52 M	4.52 M	4.52 M	4.52 M	22.2 M	22.2 M	22.2 M	22.2 M	197 K	197 K	197 K	197 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	2.6 M	4.92 M	3.19 M	1.78 M	161 K	1.57 M	8.24 M	6.71 M	217 K	890 K	1.83 M	3.76 M	585 K	1.12 M	1.82 M	3.13 M	3.13 M	3.13 M	3.13 M	8.74 M	8.74 M	8.74 M	8.74 M	2.67 M	2.67 M	2.67 M	2.67 M	11.8 M	11.8 M	11.8 M	11.8 M	197 K	197 K	32 K	197 K	14 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	1.65 M	3.83 M	1.9 M	654 K	-4.52 M	-6.15 M	-2.16 M	3.27 M	-39 K	598 K	1.16 M	3.45 M	-160 K	642 K	1.48 M	2.36 M	2.36 M	2.36 M	2.36 M	6.8 M	6.8 M	6.8 M	6.8 M	-631 K	-631 K	-631 K	-631 K	19.4 M	19.4 M	19.4 M	19.4 M	-8.25 M	-8.25 M	-8.25 M	-8.25 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	2.61 M	4.76 M	2.84 M	1.58 M	-4.52 M	-6.15 M	-2.16 M	3.9 M	-39 K	598 K	1.16 M	3.45 M	-160 K	642 K	1.48 M	2.36 M	2.36 M	2.36 M	2.36 M	6.8 M	6.8 M	6.8 M	6.8 M	-631 K	-631 K	-631 K	-631 K	19.4 M	19.4 M	19.4 M	19.4 M	-8.25 M	-8.25 M	-8.25 M	-8.25 M	-5.14 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency